Abstract 4371708: Donor Heart Transport Technology as a Determinant of Survival in Contemporary Heart Transplantation

Abstract

Background: Heart transplantation is the definitive treatment of end-stage heart failure and is a complex process involving coordination in procurement, preservation, and transport of a donor organ to a recipient. There are different heart transport methods, including the traditional static methods of Cooler and Ryobi and advanced dynamic methods, including SherpaPak and the Organ Care System (OCS). The aim of the study is to compare the post-transplant outcome of these in patients bridged with Impella 5.5. Method: A retrospective study was conducted between 2020 and 2025 after IRB approval. Patient demographics and clinical data was extracted from the medical record. Cox proportional hazards regression model was applied to identify independent predictors of mortality across 30-day, 90-day, and 1-year intervals. Results: 123 patients were included in the analysis. Age, EF and Race were similar between all groups. The transport method was a significant predictor of 1-year mortality. Use of OCS (HR=0.022, p value <0.05) and SherpaPak (HR=0.066, p value <0.05) was associated with a significant decrease in mortality compared to traditional cooler use. Across 30-day, 90-day, and 1-year intervals, OCS showed the strongest survival benefit, while SherpaPak also demonstrated reduced mortality, but less significant compared to OCS. Conclusion: Transport method is a strong predictor of 1-year post-transplant mortality, with OCS showing the most pronounced effect in reducing the risk of 1-year mortality as well as mortality across 30-day and 90-day intervals. These findings support broader adoption of advanced transport systems in clinical practice to improve post-transplant outcomes.